What should be monitored in patients receiving corticosteroids for cancer?

Monitoring blood glucose levels in patients receiving corticosteroids for cancer is essential because corticosteroids can significantly affect glucose metabolism. These medications can lead to hyperglycemia, particularly in individuals who may already have an increased risk for diabetes, such as those undergoing cancer treatment. The catabolic effects of corticosteroids can increase insulin resistance and decrease the effectiveness of insulin, contributing to elevated blood sugar levels.

In addition to diabetes management, maintaining blood glucose within a normal range is crucial because high levels can lead to further complications during cancer treatment. Patients and healthcare providers should regularly monitor glucose levels to adjust medication, diet, or other interventions as needed to maintain stability in the patient's condition. This proactive monitoring helps prevent potential complications associated with steroid use, especially during intensive cancer therapies.

While blood pressure, cholesterol, and liver function are also important to monitor in patients receiving various treatments, blood glucose is particularly critical in the context of corticosteroid therapy due to its direct impact on the patients' metabolic state and overall health during cancer treatment.